Nabota - Health Technology Insights

Daewoong Launches NABOTA in Qatar, Eyes GCC Market Growth

June 13, 2025

Daewoong Pharmaceutical has officially launched its high-purity, high-quality botulinum toxin, NABOTA, in Qatar—further reinforcing its strategy to penetrate high-potential markets in the Middle East. Health Technology

Daewoong Launches Nabota Botulinum Toxin in Saudi Arabia

February 10, 2025

Daewoong Pharmaceutical (Co-CEOs Seongsoo Park and Chang-Jae Lee), a leading healthcare company in Korea, announced the official launch of its high-purity, high-quality botulinum toxin product, NABOTA, in Saudi Arabia.

Categories

Tag: Nabota

Daewoong Launches NABOTA in Qatar, Eyes GCC Market Growth

Daewoong Launches Nabota Botulinum Toxin in Saudi Arabia

Share With

Recent Posts

SAS Unveils Ai Models And Solutions For Health Care Industry, Payer Organizations

Cohere Health Review Assist Accelerates Clinical Reviews for Health Plans with Precision AI

NCCN Launches Education Tool for Cancer Care Providers

Solera HALO Adds Tool for Configurable Digital Health Networks

BlueGenes and Levrx Bring Genetic Insights to Pharmacy Benefits

Quick Links

Insights

Get in touch

Follow Us

Our Other Brands